设为首页         

资讯内容 Content

[ACC2007]专家评论:COURAGE公布的意义以及临床运用
国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

国际循环 时间:2007/3/28 17:02:00会议评论  关键字: 
 Dr James Dove

New Orleans - One day after the early release of the COURAGE trial results, debate among doctors over the applicability of the trial findings suggests the study, while putting to rest some important questions, leaves many more unanswered. Drs William E Boden and William S Weintraub presented the trial results here at the American College of Cardiology (ACC) 2007 Scientific Sessions Tuesday. Weintraub provided quality-of-life (QoL) and economic outcomes analyses that are not included in the paper that was published online March 26, 2007 in the New England Journal of Medicine (NEJM) yesterday

                    
But one of the most burning unresolved questions, at least for the ACC, is who said what about the COURAGE trial at a sponsored satellite symposium on Sunday night, leading to a Wall Street Journal (WSJ) story Monday that prompted the ACC to lift the trial embargo one day early. "There was a statement [Sunday] night . that violated the embargo of this particular trial," ACC spokesperson Dr James Dove said. "It was reported in the media, and we felt it was egregious enough that the rest of the media should not be held accountable to the embargo. . . . We are very upset by the fact that the embargo was broken; it's an ethical violation of the practice of medicine, and we do not condone that kind of activity. Once we investigate the individual or individuals involved, then we'll decide what the sanction should be."
查看更多评论>>
 
关于本站 | 设为首页 | 加入收藏 | 站长邮箱 | 友情链接 | 版权申明

声明:国际循环网( www.icirculation.com)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。

国际循环 版权所有  2008-2024 icirculation.com  All Rights Reserved